Pre-Marketing Clinical Trial Safety eLearning Module
|
Course Badges
Pre-Marketing Clinical Trial Safety
Keyword(s)
Drug safety, Pharmacovigilance, Good pharmacovigilance practices, Adverse events, Risk Assessment, Clinical trial safety
The Pre-Marketing Clinical Trial Safety eLearning module provides a framework and details around drug safety requirements for clinical trials for drugs in humans. It includes information about safety and ethical safeguards to protect human subjects in clinical trials including informed consent, institutional review boards and independent ethics committees, and data safety monitoring boards. Individual case reporting and aggregate reporting requirements are examined in detail. A case study with exercise questions provides real-world context and enables the learner to see how the concepts presented in the module apply in real life. Finally, this module will discuss risk assessment and the pre-marketing review of safety data in a marketing application.
Credit Information
ACPE = 4
IACET = .4
IACET = .4
Description
Part of the DIA Drug Safety eLearning Program
The Pre-Marketing Clinical Trial Safety eLearning module provides a framework and details around drug safety requirements for clinical trials for drugs in humans. It includes information about safety and ethical safeguards to protect human subjects in clinical trials including informed consent, institutional review boards and independent ethics committees, and data safety monitoring boards. Individual case reporting and aggregate reporting requirements are examined in detail. A case study with exercise questions provides real-world context and enables the learner to see how the concepts presented in the module apply in real life. Finally, this module will discuss risk assessment and the pre-marketing review of safety data in a marketing application.
Featured Topics:
- Informed consent
- Institutional review boards and ethics committees
- Data and safety monitoring boards• Individual case reporting
- Aggregate reporting
- Clinical trial safety case study activity
- Risk assessment
- Pre-marketing review of safety data in a marketing application
Learning Objectives:
Upon completion of this module, learners should be able to:
- Identify the purpose and elements of informed consent in clinical trials
- Determine the roles of institutional review boards, ethics committees, and data and safety monitoring boards in clinical trials
- Recognize pre-marketing individual case reporting, aggregate reporting requirements, and review of safety data in marketing application
- Define risk assessment in clinical trials
This module take and average of 4 hours to complete.